Loading stockRelated stocks: Pharmaceutical Preparations
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Loading stockRelated stocks: Pharmaceutical Preparations
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Pharmaceutical preparations company · DE · FY ends Dec · -$81M FCF
$0.00
+$0.00 (+0.00%)
Price from 4 days ago
ROIC dropped from -52.10% to -81.47%, capital efficiency is deteriorating. Negative free cash flow of -$82M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$88M
▼ -10.9% YoY
Op. Margin
—
ROIC
-274.18%
▼ -29.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$81M
▼ -14.3% YoY
Op. Cash Flow (TTM)
-$81M
▼ -14.8% YoY
Net Debt
-$13M
Net Cash Position
Cash & Equiv.
$31M
Continue Research
SourceComputed from the 10-Q filed 14 Nov 2025, covering the period ending 30 Sept 2025, as reported to the SEC. Data last refreshed 11 Sept 2026. How this is calculated.
Price from market data, last close as of 16 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.